Drugs by condition
Drugs approved for blood clots (dvt and pulmonary embolism)
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
19
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
8
New molecular entities and new biologics
In development
4
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for blood clots (dvt and pulmonary embolism).
- Eliquis (Apixaban) · Bristol Priority reviewApr 17, 2025
- Technegas Kit (Technetium Tc-99m Labeled Carbon) · Cyclomedica Sep 29, 2023
- Savaysa (Edoxaban Tosylate) · Daiichi Sankyo INC NovelJan 8, 2015
- Eliquis (Apixaban) · Bristol Myers Squibb NovelPriority reviewOrphanDec 28, 2012
- Heparin Sodium (Heparin Sodium) · Pfizer Jul 21, 2011
All approved drugs for blood clots (dvt and pulmonary embolism), by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 53 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Factor Xa Inhibitor (3)
Lead Chelator (1)
- Draximage Dtpa Technetium Tc-99m Pentetate Kit · Jubilant · 1989
Class not listed in FDA's data (15)
- Savaysa Edoxaban Tosylate · Daiichi Sankyo INC · 2015
- Pradaxa Dabigatran Etexilate Mesylate · Boehringer Ingelheim · 2010
- Arixtra Fondaparinux Sodium · Mylan Ireland LTD · 2001
- Fragmin Dalteparin Sodium · Pfizer · 1994
- Lovenox (Preservative Free) Enoxaparin Sodium · Sanofi Aventis US · 1993
- Activase Alteplase · Genentech · 1987
- Technegas Kit Technetium Tc-99m Labeled Carbon · Cyclomedica · 2023
- Heparin Sodium Heparin Sodium · Pfizer · 2011
- Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container Heparin Sodium · B Braun · 1992
- Heparin Sodium 25,000 Units In Sodium Chloride 0.45% In Plastic Container Heparin Sodium · B Braun · 1992
- Heparin Sodium 10,000 Units In Dextrose 5% In Plastic Container Heparin Sodium · Hospira · 1985
- Heparin Sodium 25,000 Units In Sodium Chloride 0.9% In Plastic Container Heparin Sodium · Hospira · 1984
- Heparin Sodium Heparin Sodium · Fresenius Kabi USA · 1978
- Heparin Sodium Heparin Sodium · Hikma · 1972
- Heparin Sodium 25,000 Units In Sodium Chloride 0.45% Heparin Sodium · Fresenius Kabi USA · 1972
Drugs in development for blood clots (dvt and pulmonary embolism)
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- Non-immunogenic recombinant staphylokinaseFortelyzinPhase 31 trial
Supergene, LLC · Pulmonary Embolism
- TS23Phase 22 trials
Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism
- VortosiranPhase 22 trials
Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
- BAY3018250Phase 21 trial
Bayer · Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis
1 discontinued brand-name drugs whose label still names it
- Xarelto Rivaroxaban
More on blood clots (dvt and pulmonary embolism): recruiting trials · published research
Related in cardiovascular and metabolic: Type 2 diabetes · Type 1 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High cholesterol · High triglycerides · Atrial fibrillation · Stroke prevention · Coronary artery disease and heart attack
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.